Skip to content

A single-center, prospective study of the application of tinnitus rehabilitation device based on concealment and notch technology in subjective cardiac high-frequency tinnitus

A single-center, prospective study of the application of tinnitus rehabilitation device based on concealment and notch technology in subjective cardiac high-frequency tinnitus

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076145
Enrollment
Unknown
Registered
2023-09-26
Start date
2023-09-30
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tinnitus

Interventions

Test group:music therapy

Sponsors

Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Subjective tinnitus has been treated as the first or only complaint for more than 6 months; 2) Age 18 to 65 years old, regardless of gender; 3) High frequency patients with tinnitus frequency above 4000Hz; 4) The hearing threshold is within 65dB HL; 5) THI scale score = 36 points; 6) Having the ability to understand and express correctly; 7) Voluntarily sign an informed consent form; 8) No history of middle ear disease, head injury, or central nervous system disorder; 9) Not taking medication to improve inner ear circulation, nourish nerves, etc;

Exclusion criteria

Exclusion criteria: 1) those with confirmed external and middle ear lesions and retrocochlear lesions or MRI suggestive of neurovascular compression of the VIIIth cerebral nerve; 2) Those with confirmed progressive psychiatric disorders; 3) Those with suspected or confirmed history of alcohol/drug abuse; 4) Tinnitus patients with middle ear or who have undergone middle ear surgery (e.g. mastoidectomy); 5) Subjects with severe hypertension, diabetes mellitus, cardiovascular disease, vertigo; 6) Subjects who fail to complete treatment and follow-up as planned; 7) Other subjects who, in the opinion of the investigator, cannot be enrolled; 8) Subjects with conductive deafness;

Design outcomes

Primary

MeasureTime frame
Tinnitus Disability Scale;

Secondary

MeasureTime frame
pure-tone threshold audiometry;otoacoustic emission;

Countries

China

Contacts

Public ContactMinfei Qian

Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

mfqian944@aliyun.com+86 138 1640 3516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026